Boparan delivers decent print, but only just avoids covenant breach - Q3 22 earnings review

Share

Market Wrap

Boparan delivers decent print, but only just avoids covenant breach - Q3 22 earnings review

Emmet Mc Nally's avatar
  1. Emmet Mc Nally
6 min read

Boparan’s £475m 7.625% 2025 SSNs are up almost four-points following the release of Q3 22 results (to end-April) this morning (22 June). The positive reaction follows a decent uptick in EBITDA margins to levels touted at the time of the credit’s stressed refinancing in November 2020. Price negotiations signalled in Q1 22 have finally come through and lags on cost pass-throughs mostly removed. A covenant breach was effectively taken off the table, although like its Q2 22 results in March, the UK-based poultry producer ended up only barely scraping through.

Read all our public content for free

We won't spam. You can unsubscribe at any time.

What are you waiting for?

Try it out
  • We're trusted by 9 of the top 10 Investment Banks

Cookies & Privacy

We would like to use cookies to improve our service. Is that ok?